Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA)’s Basic Consolidated EPS Came In At $-3.0924

0

Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA) posted annual consolidated EPS of $-3.0924 for the period ended 2015-12-31. But basic consolidated EPS for the quarter period ended 2015-12-31 came in at $-3.0924.

Basic EPS from continuing operations

The company’s basic EPS from continuing operations for the annual period ended 2015-12-31 came in at $-3.0924 while basic EPS from continuing operations for the three-month period to 2015-12-31 was$-3.0924.

EPS contribution from parent

Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA) received $-3.0924 basic EPS contribution from its parent company in the annual period ended 2015-12-31. But for the quarter ended 2015-12-31, the parent company contributed EPS of $-3.0924.

Basic net EPS

Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA) posted basic net EPS of $-3.09 for the annual period ended 2015-12-31. For the quarter ended 2015-12-31, the company posted basic net EPS of $-3.09.

Consolidated diluted EPS

The company’s consolidated diluted EPS for the period ended 2015-12-31 was $-3.0924 while consolidated diluted EPS was $-3.0924 for the quarter ended 2015-12-31.

Basic diluted EPS

Basic diluted EPS from continuing operation for the annual period ended 2015-12-31 was $-3.0924. As for the quarter, diluted EPS from continuing operations for the three-month ended 2015-12-31 stood at $-3.0924.

Net diluted EPS

Net diluted EPS was $-3.09 for the annual period ended 2015-12-31. But net diluted EPS for the quarterly period ended 2015-12-31 stood at $-3.09.

Diluted EPS from parent

From the parent company, Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA) received diluted EPS of $-3.0924

For the annual period ended 2015-12-31, diluted EPS from Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA)’s parent company was$-3.0924. But for the quarter period ended 2015-12-31, diluted EPS contribution from the parent company was $-3.0924.

Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA)’s net basic EPS for the annual period ended 2015-12-31 was $-3.09 and for the quarter period ended 2015-12-31 it was $-3.09.

For the annual period ended 2015-12-31, the company had average basic shares outstanding of 20.321 while basic shares outstanding were 20.321 for the quarter period ended 2015-12-31.

The company’s diluted shares outstanding was 20.321 for the annual period ended 2015-12-31 is 20.321. That compared with 20.321 diluted shares outstanding for the quarter period ended 2015-12-31.

1 Chart Pattern Every Investor Should Know

This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...

Click Here to See This Now.

(Visited 9 times, 1 visits today)